CVS - CVS Health Corporation

NYSE - Nasdaq Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5
95.43B
Enterprise Value 3
177.88B
Trailing P/E
20.66
Forward P/E 1
10.29
PEG Ratio (5 yr expected) 1
3.58
Price/Sales (ttm)
0.39
Price/Book (mrq)
1.52
Enterprise Value/Revenue 3
0.73
Enterprise Value/EBITDA 6
11.29

Trading Information

Stock Price History

Beta (3Y Monthly) 0.88
52-Week Change 3-0.31%
S&P500 52-Week Change 318.80%
52 Week High 377.03
52 Week Low 351.72
50-Day Moving Average 371.71
200-Day Moving Average 361.90

Share Statistics

Avg Vol (3 month) 36.86M
Avg Vol (10 day) 36.05M
Shares Outstanding 51.3B
Float 1.3B
% Held by Insiders 10.24%
% Held by Institutions 183.80%
Shares Short (Nov 29, 2019) 420.28M
Short Ratio (Nov 29, 2019) 42.5
Short % of Float (Nov 29, 2019) 41.56%
Short % of Shares Outstanding (Nov 29, 2019) 41.56%
Shares Short (prior month Oct 31, 2019) 421.98M

Dividends & Splits

Forward Annual Dividend Rate 42
Forward Annual Dividend Yield 42.73%
Trailing Annual Dividend Rate 32.00
Trailing Annual Dividend Yield 32.73%
5 Year Average Dividend Yield 42.30
Payout Ratio 459.70%
Dividend Date 3Nov 4, 2019
Ex-Dividend Date 4Oct 23, 2019
Last Split Factor (new per old) 21/2
Last Split Date 3Jun 7, 2005

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Sep 30, 2019

Profitability

Profit Margin 1.84%
Operating Margin (ttm)4.80%

Management Effectiveness

Return on Assets (ttm)4.15%
Return on Equity (ttm)8.97%

Income Statement

Revenue (ttm)243.33B
Revenue Per Share (ttm)193.81
Quarterly Revenue Growth (yoy)36.60%
Gross Profit (ttm)30.88B
EBITDA 15.75B
Net Income Avi to Common (ttm)4.46B
Diluted EPS (ttm)3.55
Quarterly Earnings Growth (yoy)10.10%

Balance Sheet

Total Cash (mrq)7.53B
Total Cash Per Share (mrq)5.79
Total Debt (mrq)89.68B
Total Debt/Equity (mrq)142.50
Current Ratio (mrq)0.92
Book Value Per Share (mrq)48.13

Cash Flow Statement

Operating Cash Flow (ttm)12.69B
Levered Free Cash Flow (ttm)15.67B